Literature DB >> 31965843

Mining possible associations of faecal A. muciniphila colonisation patterns with host adiposity and cardiometabolic markers in an adult population.

E K Mitsou1, M Detopoulou1, A Kakali1, E Fragopoulou1, T Nomikos1, S Antonopoulou1, D B Panagiotakos1, A Kyriacou1.   

Abstract

We aimed to evaluate colonisation patterns of Akkermansia muciniphila in a Greek adult population and to investigate model-adjusted associations of A. muciniphila with host adiposity and cardiometabolic markers. Participants (n=125) underwent anthropometric, dietary, physical activity and lifestyle evaluation. Blood sampling for determination of blood lipid indices, glucose metabolism, adiponectin, lipoprotein-associated phospholipase A2 (Lp-PLA2), inflammation and oxidative stress parameters was also performed. Stool A. muciniphila presence and levels were determined by quantitative PCR and subjects were grouped based on bimodal distribution of levels (Low vs High). A. muciniphila was detected in 88.6% of participants. Overweight/obese (OW/OB) subjects were more prone in low bimodal levels of A. muciniphila compared to normal-weight (NW) individuals (58.75 vs 27.59%, P=0.004), with a 4-time greater likelihood after multi-adjusted logistic regression analysis (P=0.016). Levels of A. muciniphila were negatively associated with total cholesterol/high-density lipoprotein cholesterol (TC/HDL-C) ratio (log10:-0.009±0.004, P=0.033), whereas detection of this bacterium was negatively associated with both TC/HDL-C ratio (log10: -0.049±0.023, P=0.036) and low-density lipoprotein cholesterol/HDL-C ratio (-0.407±0.176, P=0.023). Furthermore, low bimodal levels of A. muciniphila were positively associated with fasting blood glucose (log10: 0.018±0.009, P=0.037). In terms of inflammation markers, levels of A. muciniphila were positively associated with soluble cluster of differentiation-14 (sCD14) (log10: 0.012±0.004, P=0.003) and faecal detection of this bacterium had a positive association with anti-inflammatory interleukin 10 levels (log10: 0.325±0.131, P=0.015). In addition, A. muciniphila levels were positively associated with total adiponectin (log10: 0.046±0.015, P=0.002), whereas low bimodal levels of A. muciniphila had an inverse relationship with this blood marker (log10: -0.131±0.053, P=0.016). In conclusion, we confirmed the previously reported association of A. muciniphila with metabolic health for the first time in a Greek urban population; furthermore, we shed some light to novel atherosclerotic risk markers with rather unexplored connections with A. muciniphila colonisation patterns in human subjects.

Entities:  

Keywords:  gut microbiota; inflammation; metabolic health; obesity; oxidative stress

Mesh:

Substances:

Year:  2019        PMID: 31965843     DOI: 10.3920/BM2019.0033

Source DB:  PubMed          Journal:  Benef Microbes        ISSN: 1876-2883            Impact factor:   4.205


  4 in total

1.  Akkermansia muciniphila: is it the Holy Grail for ameliorating metabolic diseases?

Authors:  Juan Yan; Lili Sheng; Houkai Li
Journal:  Gut Microbes       Date:  2021 Jan-Dec

2.  Adipose tissue is a predictor of 30-days mortality in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae.

Authors:  Piaopiao Ying; Jiajing Chen; Yinchai Ye; Jianzhong Ye; Weiyang Cai
Journal:  BMC Infect Dis       Date:  2022-02-21       Impact factor: 3.090

Review 3.  The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs.

Authors:  Marie S A Palmnäs-Bédard; Giuseppina Costabile; Claudia Vetrani; Sebastian Åberg; Yommine Hjalmarsson; Johan Dicksved; Gabriele Riccardi; Rikard Landberg
Journal:  Am J Clin Nutr       Date:  2022-10-06       Impact factor: 8.472

4.  The Prebiotic Effects of Oats on Blood Lipids, Gut Microbiota, and Short-Chain Fatty Acids in Mildly Hypercholesterolemic Subjects Compared With Rice: A Randomized, Controlled Trial.

Authors:  Dengfeng Xu; Meiyuan Feng; YiFang Chu; Shaokang Wang; Varsha Shete; Kieran M Tuohy; Feng Liu; Xirui Zhou; Alison Kamil; Da Pan; Hechun Liu; Xian Yang; Chao Yang; Baoli Zhu; Na Lv; Qian Xiong; Xin Wang; Jianqin Sun; Guiju Sun; Yuexin Yang
Journal:  Front Immunol       Date:  2021-12-09       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.